-
Exact Sciences Should Benefit from Pfizer’s News Today
Post on 12/18/19
-
Soligenix to Receive $850,000 in Non-Dilutive Funding
Post on 12/18/19
-
New York Life to Acquire Cigna’s Group Life and Disability Insurance Business
Post on 12/18/19
-
7 Reasons Teladoc Will Be a Top Growth Stock in 2020
Post on 12/17/19
-
Pfizer: A New Science-Based Pharma Wonder
Post on 12/17/19
-
FDA Advisory Committee Backs Merck's Keytruda for NMIBC
Post on 12/17/19
-
Merck Adds To Aquaculture Portfolio With Vaki Purchase
Post on 12/17/19
-
ContraFect Corp. Prices $10M Public Offering of Common Stock
Post on 12/17/19
-
TMRW Life Sciences Raises $25 Million In Series B Funding Led By 5AM Ventures
Post on 12/17/19
-
Triplet Therapeutics Launches with $59M In Financing
Post on 12/17/19
-
Merck's Latest $2.7-Billion Buy Of ArQule Brings About Precision Targeted And Diversified Approach To Cancer Therapy
Post on 12/17/19
-
Pfizer: A New Science-Based Pharma Wonder
Post on 12/17/19
-
Bristol-Myers Placed A Big Bet On Celgene’s Pipeline. Will It Pay Off For Investors?
Post on 12/17/19
-
Consonance Capital Partners To Sell Enclara Healthcare To Humana
Post on 12/16/19
-
Merck's Strong Pipeline Projects High Growth Potential
Post on 12/16/19
-
Better Buy: Eli Lilly vs. Merck
Post on 12/16/19
-
Better Buy: AbbVie vs. Merck
Post on 12/16/19
-
Why Teladoc Health Is Risky to Own
Post on 12/16/19
-
Intercept Provides Regulatory Update
Post on 12/15/19
-
Aquestive Therapeutics Announces Proposed Public Offering of Common Stock
Post on 12/15/19
-
Capital Health Medical Group Adds Bucks County OB/GYN Practice to Growing Team of Specialists
Post on 12/15/19
-
HealthSTAR Communications Named One of the Most Innovative Companies of 2019 by PM360
Post on 12/15/19
-
Rocket Pharmaceuticals Closes Public Offering
Post on 12/15/19
-
After Its Celgene Acquisition, Bristol-Myers Squibb's Future Looks Bright
Post on 12/13/19
-
OncoSec CEO Daniel O’Connor Sends Letter to Fellow Shareholders
Post on 12/12/19